HOME › DRUGS › MOGAMULIZUMAB
ACTIVE SUBSTANCE / INN

MOGAMULIZUMAB

Brand name(s): Poteligeo
EMA LISTED
AUTHORISED
Sezary Syndrome;Mycosis Fungoides
ACTIVE SUBSTANCE
Mogamulizumab
REGULATORS
EMA
SPONSORS / MAH
Kyowa Kirin Holdings B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PoteligeoKyowa Kirin Holdings B.V.Authorised22/11/2018Sezary Syndrome;Mycosis Fungoides

FULL INTELLIGENCE ON MOGAMULIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →